Poland· PL-100142978
Magnezu siarczan
A medicinal product containing magnesii sulfas, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Magnesii sulfas
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909994119116
- gtin05909994119123
- gtin05909994119130
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Magnesii sulfas in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAquaDerm Hydrous ointmentImpectron Ltd
- NetherlandsMagnesiumsulfaat Eureco-Pharma 100 mg/ml, oplossing voor injectieEureco-Pharma B.V.
- FranceSPASMAG INJECTABLE, solution injectable (IV) en ampouleGRIMBERG
- SpainSULFATO DE MAGNESIO ALTAN 150 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFGAltan Pharmaceuticals Sa
- CanadaMAGNESIUM SULFATE IN WATER FOR INJECTIONBAXTER CORPORATION
- United States50% MAGNESIUM SULFATEHF Acquisition Co. LLC, DBA Health First
- FinlandAddex-MagnesiumsulfaattiFresenius Kabi AB
- Japan硫酸マグネシウム水和物
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Denmark · Magnesiumsulfat Sad
- France · Sulfate De Magnesium Renaudin
- United Kingdom (Northern Ireland) · Magnesium Sulphate Phoenix Labs
- Greece · Magnesium Sulfate Ariti
- Ireland · Magnesium Sulfate Foran Healthcare
- Netherlands · Magnesiiumsulfaat Teva, Magnesiumsulfaat Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3898b6ac-5875-4e1d-b407-593b56de0386 GET /v1/drugs/3898b6ac-5875-4e1d-b407-593b56de0386?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu",
"source": "urpl",
"strength": "-",
"packaging": "05909994119116 ¦ OTC ¦ 28567\n1 op. 25 g\n05909994119123 ¦ OTC ¦ 28568\n1 op. 50 g\n05909994119130 ¦ OTC ¦ 28569\n1 op. 100 g",
"substance": "Magnesii sulfas 1 g/ 1 g",
"common_name": "Magnesii sulfas",
"pl_product_id": "100142978",
"pozwolenie_nr": "IL-1191/ChF",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about magnesii sulfas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.